Europe Markets: Vaccine hopes and M&A action power European stocks and U.S. equity futures
European stocks marched higher on Monday, alongside U.S. equity futures, driven by vaccine hopes, mergers and acquisitions news.
The Stoxx Europe 600 index SXXP,
Investors will hear from the Federal Reserve, the Bank of England and the Bank of Japan in the coming days in a busy week for central bank meetings.
Wall Street was also pointing to a stronger start, with Nasdaq-100 futures NQ00,
Those gains came on the heels of a losing week for Wall Street, with the Dow DJIA,
Renewed hopes over a coronavirus vaccine also helped improved sentiment at the beginning of the week.
Pfizer Inc.’s PFE,
Oxford University also announced Saturday it would resume a trial for the coronavirus candidate it’s developing with AstraZeneca AZN,
U.S.-based Gilead Sciences Inc. GILD announced a $ 21 billion deal on Sunday to buy biotech Immunomedics Inc. IMMU, maker of a key breast-cancer drug.
Japanese technology conglomerate SoftBank Group Corp. announced a $ 40 billion deal late Sunday to sell U.K.-based microprocessor designer Arm Holdings to chipmaker Nvidia NVDA,
The technology sector was also lifted by M&A, with shares of German software group SAP SE SAP,
And the race for TikTok is heating up. Software group Oracle Corp. ORCL,
Elsewhere, Euronext NV ENX,
Let’s block ads! (Why?)
, MarketWatch.com – Top Stories reports